Press "esc" to clear
Go to Advanced Search

Showing results

110 of 6202
Embargo will expire:
10-Dec-2018 11:00 AM EST
Released to reporters:
9-Dec-2018 11:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 10-Dec-2018 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

cheresh_david_UCSDHealth.jpg

Article ID: 705131

UC San Diego Researcher Gets $4 Million NCI Award to Study Cancer Drug Resistance, Spread

University of California San Diego Health

David Cheresh, Distinguished Professor at University of California San Diego School of Medicine, received $4.2 million National Cancer Institute Outstanding Investigator Award to continue his research into cancer’s ability to overcome stress, gain drug resistance and metastasize.

Released:
7-Dec-2018 2:05 PM EST
Embargo will expire:
10-Dec-2018 2:00 PM EST
Released to reporters:
7-Dec-2018 1:05 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 10-Dec-2018 2:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

187296_web.jpg

Article ID: 705055

An ancient strain of plague may have led to the decline of Neolithic Europeans

Cell Press

A team of researchers from France, Sweden, and Denmark have identified a new strain of Yersinia pestis, the bacteria that causes plague, in DNA extracted from 5,000-year-old human remains. Their analyses, publishing December 6 in the journal Cell, suggest that this strain is the closest ever identified to the genetic origin of plague.

Released:
6-Dec-2018 12:45 PM EST
Embargo will expire:
11-Dec-2018 11:00 AM EST
Released to reporters:
6-Dec-2018 12:00 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 11-Dec-2018 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Protein_SugarGlycoprotein_iStock-157444580.jpg

Article ID: 704972

New Molecular Tool Identifies Sugar-Protein Attachments

Johns Hopkins Medicine

Researchers at Johns Hopkins Medicine have developed a new molecular tool they call EXoO, which decodes where on proteins specific sugars are attached—a possible modification due to disease. The study, published in issue 14 of Molecular Systems Biology, describes the development of the tool and its successful use on human blood, tumors and immune cells.

Released:
6-Dec-2018 9:00 AM EST

Article ID: 704999

Engineered DNA-encoded PCSK9 Inhibitors May Provide an Effective Alternative for Treating High Cholesterol

Wistar Institute

Researchers at The Wistar Institute have developed novel synthetic DNA-encoded monoclonal antibodies (DMAbs) directed against PCSK9, a protein key to regulating cholesterol levels in the bloodstream.

Released:
5-Dec-2018 3:30 PM EST
TransgenicMouseModelgraphic.png

Article ID: 704984

Southern Research Introduces Transgenic Mouse Model in Support of Immuno-Oncology Therapeutic Development

Southern Research

Southern Research has announced the Transgenic Mouse Human PD-1/L1 Model, its newest service offering in support of immuno-oncology (IO) therapeutic development.

Released:
5-Dec-2018 2:15 PM EST

Showing results

110 of 6202

Chat now!